Overview
- Reviews the latest developments in pharmaceutical biotechnology
- Collates up-to-date information about biologic and biosimilar medicines
- Outlines the main clinical applications of biopharmaceuticals/biological medicines
Part of the book series: Advances in Biochemical Engineering/Biotechnology (ABE, volume 171)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (11 chapters)
-
Front Matter
-
Back Matter
Keywords
About this book
This book offers an authoritative review of biopharmaceuticals and their clinical relevance. Biopharmaceuticals have been showing high therapeutic potential by means of biological and biosimilar medicines, particularly for the treatment of cancer, chronic diseases (e.g. diabetes, Crohn's disease, psoriasis and rheumatoid arthritis), neurodegenerative disorders (e.g. multiple sclerosis), and they have also been contributing to the progress of innovative therapies such as assisted reproductive medicine. Since the eighties, several biopharmaceuticals have been approved and, due to patents expiration, many biosimilars are also marketed.
In this book, readers will find the most relevant updated information about the main clinical applications of pharmaceutical biotechnology. The authors provide expert analysis about the industrial challenges of recombinant proteins and the different classes of biopharmaceuticals, including monoclonal antibodies, vaccines, growth factors and stem cells. Topics such as bioprinting technologies in tissue engineering, gene therapy and personalized medicine are also covered in this book. Professionals, students and researchers interested in this field will find this work an important account.
Editors and Affiliations
About the editors
Professor Ana Catarina Silva is an Assistant Professor of Pharmaceutical Technology and Biotechnology, and a Researcher at the Applied Molecular Biosciences Unit (UCIBIO) and UFP Energy, Environment and Health Research Unit (FP-ENAS), where she is currently developing lipid-based nanosystems to improve drug delivery and alternative systems to improve delivery of biopharmaceuticals. She has authored a number of scientific publications, and served as a referee for various international funding agencies.
Professor João Nuno Moreira is a group leader at the Center for Neuroscience and Cell Biology (CNC) and Assistant Professor with “Habilitation” (and Tenure) at the Faculty of Pharmacy, University of Coimbra, Portugal. His scientific work focuses on lipid-based nanosystems for targeted drug delivery and formulation of proteins. He is a co-author of several publications in peer-reviewed journals, 9 book chapters and 10 filed patents (3 of which have been grantedin the United States and 2 in Europe).
Professor José Manuel Sousa Lobo is Head of the Laboratory of Pharmaceutical Technology and Executive Council Director of the FFUP. He is also President of the Portuguese Pharmacopoeia Commission. An expert on industrial pharmacy, he is responsible for Quality Overall Summaries for the EMA, and is an investigator at UCIBIO.
Dr. Hugo Almeida holds a PhD in Pharmaceutical Sciences, and is Technical Director of a Medical Device company. He has authored numerous scientific publications, and his main research focuses on the application of stimuli-responsive polymers and lipid-based nanocarriers in ophthalmic drug delivery systems..
Bibliographic Information
Book Title: Current Applications of Pharmaceutical Biotechnology
Editors: Ana Catarina Silva, João Nuno Moreira, José Manuel Sousa Lobo, Hugo Almeida
Series Title: Advances in Biochemical Engineering/Biotechnology
DOI: https://doi.org/10.1007/978-3-030-40464-2
Publisher: Springer Cham
eBook Packages: Chemistry and Materials Science, Chemistry and Material Science (R0)
Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2020
Hardcover ISBN: 978-3-030-40463-5Published: 07 February 2020
Softcover ISBN: 978-3-030-40466-6Published: 07 February 2021
eBook ISBN: 978-3-030-40464-2Published: 06 February 2020
Series ISSN: 0724-6145
Series E-ISSN: 1616-8542
Edition Number: 1
Number of Pages: VIII, 400
Number of Illustrations: 56 b/w illustrations, 24 illustrations in colour
Topics: Biotechnology, Protein Science, Pharmaceutical Sciences/Technology, Industrial Chemistry/Chemical Engineering, Regenerative Medicine/Tissue Engineering, Human Genetics